Emily Crawford

14.8k total citations · 2 hit papers
83 papers, 8.0k citations indexed

About

Emily Crawford is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Emily Crawford has authored 83 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in Emily Crawford's work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Emily Crawford is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Emily Crawford collaborates with scholars based in United States, Canada and United Kingdom. Emily Crawford's co-authors include D. D. Peck, Kenneth N. Ross, Todd R. Golub, Justin Lamb, Eric S. Lander, Scott A. Armstrong, Stephen J. Haggarty, Steven A. Carr, Paul A. Clemons and Michael Reich and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Emily Crawford

79 papers receiving 7.8k citations

Hit Papers

The Connectivity Map: Using Gene-Expression Signatu... 1992 2026 2003 2014 2006 1992 1000 2.0k 3.0k

Peers

Emily Crawford
Paul A. Clarke United Kingdom
Purvesh Khatri United States
Susan L. McGovern United States
Fuchu He China
Jun O. Liu United States
Scott D. Patterson United States
Gang Chen China
Dirk B. Mendel United States
Graeme I. Murray United Kingdom
Paul A. Clarke United Kingdom
Emily Crawford
Citations per year, relative to Emily Crawford Emily Crawford (= 1×) peers Paul A. Clarke

Countries citing papers authored by Emily Crawford

Since Specialization
Citations

This map shows the geographic impact of Emily Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Crawford more than expected).

Fields of papers citing papers by Emily Crawford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Crawford. The network helps show where Emily Crawford may publish in the future.

Co-authorship network of co-authors of Emily Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Crawford. A scholar is included among the top collaborators of Emily Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Crawford. Emily Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Hyeok‐Hee, Emily Crawford, So Mi Jemma Cho, et al.. (2025). Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023. Journal of the American College of Cardiology. 86(25). 2577–2593.
2.
Hemmerling, Anke, Steve Miller, Sanja Huibner, et al.. (2024). Vaginal Lactobacillus crispatus persistence following application of a live biotherapeutic product: colonization phenotypes and genital immune impact. Microbiome. 12(1). 110–110. 9 indexed citations
3.
Tana, Michele, Arielle Klepper, Amy Lyden, et al.. (2022). Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLoS ONE. 17(3). e0264307–e0264307. 5 indexed citations
4.
Tessema, Sofonías K., Nicholas J. Hathaway, Noam Teyssier, et al.. (2020). Sensitive, Highly Multiplexed Sequencing of Microhaplotypes From the Plasmodium falciparum Heterozygome. The Journal of Infectious Diseases. 225(7). 1227–1237. 35 indexed citations
5.
Fridey, Joy, Susan L. Stramer, Ashok Nambiar, et al.. (2020). Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction. Transfusion. 60(9). 1960–1969. 18 indexed citations
6.
Csörgő, Bálint, Lina M León, Alejandro Vasquez-Rifo, et al.. (2020). A compact Cascade–Cas3 system for targeted genome engineering. Nature Methods. 17(12). 1183–1190. 130 indexed citations
7.
Rackaityte, Elze, Joanna Halkias, Elle Fukui, et al.. (2020). Viable bacterial colonization is highly limited in the human intestine in utero. Nature Medicine. 26(4). 599–607. 177 indexed citations
8.
Briggs, Jessica, Noam Teyssier, Joaniter I. Nankabirwa, et al.. (2020). Sex-based differences in clearance of chronic Plasmodium falciparum infection. eLife. 9. 47 indexed citations
9.
Woodworth, Michael H., Emily Crawford, Sarah B. Doernberg, et al.. (2019). Sentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India. Microbial Drug Resistance. 25(5). 677–680. 11 indexed citations
10.
Crawford, Emily, Jenai Quan, Jeremy A. Horst, et al.. (2017). Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733. PLoS ONE. 12(5). e0178163–e0178163. 42 indexed citations
11.
Wilson, Michael R., Liv Zimmermann, Emily Crawford, et al.. (2016). Acute West Nile Virus Meningoencephalitis Diagnosed Via Metagenomic Deep Sequencing of Cerebrospinal Fluid in a Renal Transplant Patient. American Journal of Transplantation. 17(3). 803–808. 75 indexed citations
12.
Doan, Thuy, Michael R. Wilson, Emily Crawford, et al.. (2016). Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens. Genome Medicine. 8(1). 90–90. 141 indexed citations
13.
Crawford, Emily, Julia E. Seaman, Nicholas J. Agard, et al.. (2012). The DegraBase: A Database of Proteolysis in Healthy and Apoptotic Human Cells. Molecular & Cellular Proteomics. 12(3). 813–824. 119 indexed citations
14.
Crawford, Emily, et al.. (2009). Design of a heterotetrameric coiled coil. Protein Science. 18(2). 329–336. 20 indexed citations
15.
Lucia, M. Scott, Jonathan I. Epstein, Phyllis J. Goodman, et al.. (2007). Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 99(18). 1375–1383. 174 indexed citations
16.
Crawford, Emily & Allen Kurta. (2000). Color of pitfall affects trapping success for anurans and shrews. Herpetological review. 31(4). 222–224. 7 indexed citations
19.
McLeod, D. G. R., Ralph C. Benson, Mario A. Eisenberger, et al.. (1993). The use of flutamide in hormone-refractory metastatic prostate cancer. Cancer. 72(S12). 3870–3873. 14 indexed citations
20.
Crawford, Emily. (1992). Challenges in the Management of Prostate Cancer. British Journal of Urology. 70(s1). 33–38. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026